Circulating microRNA-122 as a potential biomarker for liver injury

Molecular Medicine Reports

Volumn 5, Issue 6, 2012, Pages 1428-1432

  Ding, Xianfeng ^a   Ding, Jianv ^a   Ning, Jing ^c,e,f   Yi, Fan ^b   Chen, Jiankui ^e   Zhao, Deyao ^a   Zheng, Jiaping ^d   Liang, Zicai ^b   Hu, Zhiyuan ^c   Du, Quan ^b,g  

^a ZHEJIANG SCI TECH UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

^c Beijing Proteome Research Center   (China)

^d ZHEJIANG CANCER HOSPITAL   (China)

^e BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^f Chinese People's Armed Police Forces   (China)

^g PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Biomarker; Circulating microRNA; Liver injury

Indexed keywords

ALANINE AMINOTRANSFERASE; MICRORNA 122; PARAQUAT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER TOXICITY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; DRUG-INDUCED LIVER INJURY; HEPATITIS B; HUMANS; LIVER NEOPLASMS; MICRORNAS; PROGNOSIS;

HEPATITIS C VIRUS;

EID: 84860744644     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.838     Document Type: Article

References (18)

1. Halkes S, van den Berg A, Hoekstra M, du Pont J and Kreis R: Transaminase and alkaline phosphatase activity in the serum of burn patients treated with highly purified tannic acid. Burns 28: 449-453, 2002. (Pubitemid 34876875)
2. Korones DN, Brown MR and Palis J: 'Liver function tests' are not always tests of liver function. Am J Hematol 66: 46-48, 2001. (Pubitemid 32006322)
3. Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS and Seeff LB: Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 46: 2050-2068, 2000.
4. Jopling CL, Yi M, Lancaster AM, Lemon SM and Sarnow P: Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309: 1577-1581, 2005. (Pubitemid 41266486)
5. Randall G, Panis M, Cooper JD, et al: Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci USA 104: 12884-12889, 2007. (Pubitemid 47255249)
6. Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al: Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327: 198-201, 2010.
7. Lee YS and Dutta A: MicroRNAs in cancer. Annu Rev Pathol 4: 199-227, 2009.
8. Dillhoff M, Wojcik SE and Bloomston M: MicroRNAs in solid tumors. J Surg Res 154: 349-354, 2009.
9. Chen X, Ba Y, Ma L, et al: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006, 2008.
10. Mitchell PS, Parkin RK, Kroh EM, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
11. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE, et al: Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 106: 4402-4407, 2009.
12. Esau C, Davis S, Murray SF, et al: miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3: 87-98, 2006.
13. Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M and Stoffel M: Silencing of microRNAs in vivo with 'antagomirs'. Nature 438: 685-689, 2005.
14. Elmén J, Lindow M, Schütz S, et al: LNA-mediated microRNA silencing in non-human primates. Nature 452: 896-899, 2008. (Pubitemid 351550859)
15. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W and Tuschl T: Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735-739, 2002. (Pubitemid 34455427)
16. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH and Filipowicz W: Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 15: 31-33, 2009.
17. Brow DA and Guthrie C: Spliceosomal RNA U6 is remarkably conserved from yeast to mammals. Nature 334: 213-218, 1988.
18. Peltier HJ and Latham GJ: Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14: 844-852, 2008. (Pubitemid 351574906)